These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32992320)

  • 1. Effectiveness of Chemoradiotherapy for Metachronous Esophageal Squamous Cell Carcinoma.
    Suzuki Y; Kikuchi D; Hoteya S; Okamura T; Ochiai Y; Hayasaka J; Dan N; Mitsunaga Y; Tanaka M; Odagiri H; Nomura K; Yamashita S; Matsui A; Iizuka T
    Digestion; 2021; 102(4):622-629. PubMed ID: 32992320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristic of esophageal cancer without lugol-voiding lesions in the background esophagus.
    Kuwabara H; Chiba H; Tachikawa J; Okada N; Ashikari K; Arimoto J; Nakaoka M; Sakai E; Goto T; Ohata K
    Dig Endosc; 2020 May; 32(4):621-627. PubMed ID: 31965622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADH1B and ALDH2 are associated with metachronous SCC after endoscopic submucosal dissection of esophageal squamous cell carcinoma.
    Kagemoto K; Urabe Y; Miwata T; Oka S; Ochi H; Kitadai Y; Tanaka S; Chayama K
    Cancer Med; 2016 Jul; 5(7):1397-404. PubMed ID: 27038040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of esophageal squamous cell carcinomas and lugol-voiding lesions in patients with head and neck squamous cell carcinoma.
    Fukuhara T; Hiyama T; Tanaka S; Oka S; Yoshihara M; Arihiro K; Chayama K
    J Clin Gastroenterol; 2010 Feb; 44(2):e27-33. PubMed ID: 19730116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additional chemoradiotherapy for superficial esophageal squamous cell carcinoma after near-circumferential or full-circumferential noncurative endoscopic submucosal dissection: a retrospective study.
    Tasaki Y; Yamazaki T; Miyazaki S; Takeda T; Nakatake M; Nakamura D; Takahira A; Honda K; Egawa A; Yamaguchi N; Nakao K; Toya R
    BMC Gastroenterol; 2024 Jul; 24(1):232. PubMed ID: 39044174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blue laser imaging identifies endoscopic findings corresponding to metachronous esophageal squamous cell carcinoma.
    Azuma Y; Dohi O; Naito Y; Yasuda T; Yoshida T; Ishida T; Kitae H; Matsumura S; Doi T; Hirose R; Inoue K; Yoshida N; Kamada K; Uchiyama K; Takagi T; Ishikawa T; Konishi H; Nishimura A; Kishimoto M; Itoh Y
    Esophagus; 2022 Apr; 19(2):278-286. PubMed ID: 34773554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma.
    Tanaka T; Ueno M; Iizuka T; Hoteya S; Haruta S; Udagawa H
    Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 30980070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma in Taiwan.
    Hsu MH; Wang WL; Chen TH; Tai CM; Wang HP; Lee CT
    BMC Gastroenterol; 2021 Aug; 21(1):308. PubMed ID: 34344303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metachronous carcinogenesis of superficial esophagus squamous cell carcinoma after endoscopic submucosal dissection: incidence and risk stratification during long-term observation.
    Ogasawara N; Kikuchi D; Inoshita N; Nakayama A; Kohno K; Ochiai Y; Hayasaka J; Suzuki Y; Dan N; Okamura T; Mitsunaga Y; Tanaka M; Nomura K; Odagiri H; Yamashita S; Matsui A; Hoteya S; Iizuka T
    Esophagus; 2021 Oct; 18(4):806-816. PubMed ID: 33974189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoradiation versus surgery for superficial esophageal squamous cell carcinoma after noncurative endoscopic submucosal dissection: comparison of long-term oncologic outcomes.
    Suzuki G; Yamazaki H; Aibe N; Masui K; Kimoto T; Nagasawa S; Watanabe S; Seri S; Asato A; Shiozaki A; Fujiwara H; Konishi H; Dohi O; Ishikawa T; Elsaleh H; Yamada K
    Radiat Oncol; 2022 Nov; 17(1):191. PubMed ID: 36401267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors of metachronous recurrence after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
    Kim GH; Min YW; Lee H; Min BH; Lee JH; Rhee PL; Kim JJ
    PLoS One; 2020; 15(9):e0238113. PubMed ID: 32886924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes of combined endoscopic resection and chemoradiotherapy for esophageal squamous cell carcinoma with submucosal invasion.
    Yoshimizu S; Yoshio T; Ishiyama A; Tsuchida T; Horiuchi Y; Omae M; Hirasawa T; Asari T; Chin K; Fujisaki J
    Dig Liver Dis; 2018 Aug; 50(8):833-838. PubMed ID: 29477349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metachronous multiple esophageal squamous cell carcinomas and Lugol-voiding lesions after endoscopic mucosal resection.
    Urabe Y; Hiyama T; Tanaka S; Oka S; Yoshihara M; Arihiro K; Chayama K
    Endoscopy; 2009 Apr; 41(4):304-9. PubMed ID: 19340732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic findings corresponding to multiple Lugol-voiding lesions in the esophageal background mucosa.
    Matsuno K; Ishihara R; Nakagawa K; Ohmori M; Iwagami H; Inoue S; Iwatsubo T; Nakahira H; Matsuura N; Shichijyo S; Maekawa A; Takashi K; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Matsunaga T
    J Gastroenterol Hepatol; 2019 Feb; 34(2):390-396. PubMed ID: 30101499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a risk model for the development of metachronous squamous cell carcinoma after endoscopic resection of esopahageal squamous cell carcinoma.
    Urabe Y; Kagemoto K; Nakamura K; Mizumoto T; Sanomura Y; Oka S; Ochi H; Tanaka S; Chayama K
    Esophagus; 2019 Apr; 16(2):141-146. PubMed ID: 30173282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive risk evaluation for metachronous carcinogenesis after endoscopic submucosal dissection of superficial pharyngeal squamous cell carcinoma.
    Ogasawara N; Kikuchi D; Tanaka M; Ochiai Y; Okamura T; Hayasaka J; Suzuki Y; Mitsunaga Y; Nomura K; Odagiri H; Yamashita S; Matsui A; Hoteya S
    Esophagus; 2022 Jul; 19(3):460-468. PubMed ID: 35099639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Alcohol Use Disorders Identification Test and the risk of metachronous cancer after endoscopic resection of esophageal cancer.
    Yokoyama A; Katada C; Yokoyama T; Takizawa K; Yano T; Oda I; Shimizu Y; Nakanishi H; Koike T; Hirao M; Okada H; Yoshii T; Katagiri A; Yamanouchi T; Matsuo Y; Kawakubo H; Kobayashi N; Ishikawa H; Muto M
    Carcinogenesis; 2020 Aug; 41(8):1049-1056. PubMed ID: 32157279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High incidence of lung cancer death after curative endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
    Tajiri A; Tsujii Y; Nishida T; Inoue T; Maekawa A; Kitamura S; Yamaguchi S; Nishihara A; Yamada T; Ogiyama H; Murayama Y; Yamamoto S; Egawa S; Uema R; Yoshihara T; Hayashi Y; Takehara T
    Cancer Med; 2024 May; 13(9):e7242. PubMed ID: 38733176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic strategies following endoscopic submucosal dissection for T1a-MM/T1b-SM1 esophageal squamous cell carcinoma: comparisons of long-term outcomes with propensity score-matched analysis.
    Li J; Wang L; Shi X; Chen J; Jin Z; Zou D; Li Z; Liu F
    Surg Endosc; 2023 Mar; 37(3):1761-1770. PubMed ID: 36220991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of chemoradiation on the development of second primary cancers after endoscopic resection of T1 esophageal squamous cell carcinoma.
    Yoshio T; Minashi K; Mizusawa J; Morita Y; Tajika M; Fujiwara J; Yamamoto Y; Katada C; Hori S; Yano T; Takizawa K; Fukuda H; Muto M
    Esophagus; 2022 Jul; 19(3):469-476. PubMed ID: 35320430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.